Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. - Wikidata - wikimedia - TriplyDB

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.

http://www.wikidata.org/entity/Q33370834

about

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.Update on therapeutic options in Waldenström macroglobulinemia Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia.Waldenstrom macroglobulinemia Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia New Therapeutic Approaches for Waldenstrom Macroglobulinemia Waldenstrom macroglobulinemia: prognosis and management.Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis Novel agents in Waldenstrom Macroglobulinemia.Candidate genes of Waldenström's macroglobulinemia: current evidence and research.Emerging drugs for Waldenström's macroglobulinemia.Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique.Risk stratification in Waldenström macroglobulinemia.Molecular pathogenesis of Waldenstrom's macroglobulinemia.Genetic factors and pathogenesis of Waldenström's macroglobulinemia.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models Novel treatment options for Waldenström macroglobulinemia Waldenström macroglobulinemia: from biology to treatment.Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.Current options to manage Waldenström's macroglobulinemia.SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.What's new in Waldenström macroglobulinemia.Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.Waldenstrom's Macroglobulinemia: An Update.Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.Waldenström's macroglobulinemia in a dog with a bleeding diathesis.Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström's macroglobulinemia.

P2860

Q28244041-FB88F71F-6625-4D5F-81E0-CC8C77629492 Q28290236-EA28BDCC-D561-4FF2-BF16-5487038925F0 Q28291793-C646E21B-3F8D-40A9-AF53-4DB2F21D496D Q28297940-416F2363-0365-47D5-B906-7DB291B3B320 Q28304195-DFFA30DA-D71B-4973-B109-8B60B0CE995D Q33395066-BD7D035C-45E8-4C50-B734-A76693D6549C Q33400780-FA35175B-269E-4F69-9979-0D763CA42330 Q33408517-BAC591C9-C2D6-4F85-B877-E666AEDE6F2B Q33421444-B15E1AF3-D9D0-4D1C-AFBF-48445FE34777 Q33434251-E9F9142A-DED1-40A7-8888-EC5EA992EC0A Q33438490-65AAFE43-A90D-47E1-85AC-888D2893E512 Q33711127-36B2E158-CEB6-4CF7-9F97-16845E62F949 Q35097328-8866D794-E396-4038-9287-775C93E46739 Q35153656-A594D5BD-FF55-4B4B-8852-F9694D40C383 Q35176177-BBAC470A-CE3E-4805-B90D-95424A72B3DD Q35244911-F8AFB507-072E-4D2F-9ABD-71F2153F021C Q35806665-882A4426-0B27-4D56-8A52-456FB60F6AB5 Q36117791-44520263-0370-45BF-9C83-B6E5D2FE6DF8 Q37074275-F8DB7CA3-4E0B-4175-B473-81B206314089 Q37847176-447920F7-97C2-49D3-B5F6-F46505F02D01 Q37923308-E00411BE-74E6-4489-8723-3525FD94FC68 Q37999886-BFF8BC9F-B4B2-43CD-9F8E-730D31553BD9 Q38024773-BB591EE8-094C-4797-B4F2-65E9D38FC17E Q38125430-B71B52B6-B196-4D61-A4DB-8150A06CFBEA Q38150849-F4C77FA0-A3B3-4580-8F14-765E3E305E19 Q38167433-FCD18D22-54BD-4089-A44B-38C1B99DC1B2 Q38176969-7C150E2C-4BB1-4665-AA41-52C864A1A72E Q38774535-D037E778-EA01-4EA8-8FDC-13341E9D8DA8 Q38970612-345C75B8-D0A5-49DB-BCAF-7DECA81565F8 Q39044362-A851072B-1C2F-4F8E-8912-0B785861CBEF Q39358109-51F94928-11BE-4A1E-B9BF-1136CB3DF554 Q39428271-2E1BE9A5-090E-495F-941B-38C0F3EE47B1 Q39738249-48C39D20-EC41-4107-AFC3-0142AD6F72BA Q42861257-C86461A8-1594-4617-A29F-9E47A61299DD Q42905789-E658E6C2-B00D-4EA2-A2CC-152817616E94 Q42910816-5886EB36-4212-4F36-87B4-F434B2A56C63 Q47736653-5687B220-F07D-4596-A4DC-DBA2F7B00235 Q48158113-4647482B-9A18-48E3-856D-1710FD0AC65D Q51016549-ADE910A3-807E-4DC7-B8E8-C2242E3C3649 Q52717194-9492C48D-1C3E-44D1-8D70-3CB623546559

P2860

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.

http://www.wikidata.org/entity/Q33370834

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@ast

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@en

type

label

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@ast

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@en

prefLabel

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@ast

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@en

P1433

Q33370834-EC8DCAE5-6B1E-4CC5-B709-3C4B8BA9B8FB

P1476

Q33370834-15C5E9DA-1D01-4583-AD56-EB5049CB6C90

P2093

Q33370834-0E7C5693-A5C4-4D99-9812-A3B0D67F83B4

Q33370834-1B52DE6D-2F55-4DEB-BD45-8F967CD5A77D

Q33370834-50E11D0F-E70B-42AA-A2F1-4771BCC6F3CA

Q33370834-773B2E06-FD3B-428D-AFDB-45E547CF7FB3

Q33370834-C7CDFF81-F779-40B2-A4B2-C0F6FC0A1105

Q33370834-D4950B84-BADF-407A-B237-ED37A2D4F836

Q33370834-DBBD8D10-BDDA-40AE-848D-5D4BB9D2213C

Q33370834-E2138A8E-5C66-45D8-A1EB-AD1BAE774864

Q33370834-EE038779-D98A-410A-897B-8473A3A07F53

Q33370834-F6176FFD-E791-4FBF-9B84-926C1891BEB7

P2860

Q33370834-1B71124F-08C4-40B6-8995-C92D18B3184A

Q33370834-575D8404-A2A3-4118-940C-21D7C9B30D96

Q33370834-6953E9B0-FBAD-4048-A8F9-42A91E4D0227

Q33370834-81CE6E8F-2518-4445-B7D7-2D047E29E8BF

Q33370834-84611496-97FA-433D-95FB-3352BC0ADBFB

Q33370834-B00D5122-92AA-4BC0-81AA-D43BD3D1AC1D

Q33370834-C2482295-7C0D-475A-8010-636E532229A1

Q33370834-C4938579-AFFE-4681-A2A9-F89382B28D49

P304

Q33370834-66710649-E822-4547-BA66-A520B5E14A65

P31

Q33370834-6B99545F-AB01-4053-8E83-28D77A09D563

P356

Q33370834-04830E6C-565B-4B32-A918-19B025C75D8A

P407

Q33370834-3CF1735A-DB90-4046-8BEB-E277A90F8854

P433

Q33370834-DCB9B1B4-41F2-4FC2-BF91-5BF1539580C5

P478

Q33370834-CF8B7DE6-A67C-4271-B3CE-D214133089DD

P50

Q33370834-57C680A6-D3C3-4B87-9276-CFFDE251D4D3

Q33370834-89634AD3-10EC-4CD8-A5ED-2EC1F2AB5C8F

Q33370834-8BCE58D3-2971-4E2B-882E-AB07E63031AC

Q33370834-D572EC2A-627C-4B0F-9486-5914DF87EAAD

Q33370834-D94C983E-75AA-446A-BC42-36A5B6139CE8

Q33370834-E40C1786-EFA4-45AA-B674-82DC7645F960

P577

Q33370834-53A5B76E-A7B5-4661-AE24-8A12DB5B2C75

P5875

Q33370834-B892E0B5-FC6D-48B4-82BC-1ECEACE18682

P698

Q33370834-78AEB1F8-9727-472F-BF2E-90EAE084DE99

P356

J.1365-2141.2006.06003.X

P1433

British Journal of Haematology

P1476

Prognostic model for disease-s ...... aldenstrom macroglobulinaemia.

@en

P2093

Dirk R Larson

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

John A Lust

http://www.w3.org/2001/XMLSchema#string

Matthew F Plevak

http://www.w3.org/2001/XMLSchema#string

Philip R Greipp

http://www.w3.org/2001/XMLSchema#string

Randi J Hoffmann

http://www.w3.org/2001/XMLSchema#string

Robert C Wolf

http://www.w3.org/2001/XMLSchema#string

Stephen R Zeldenrust

http://www.w3.org/2001/XMLSchema#string

Terry M Therneau

http://www.w3.org/2001/XMLSchema#string

Thomas E Witzig

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Waldenström macroglobulinaemia.

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).

The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.

Prognostic factors in symptomatic Waldenstrom's macroglobulinemia

P304

158-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2006.06003.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Angela Dispenzieri

S. Vincent Rajkumar

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7169484

http://www.w3.org/2001/XMLSchema#string

P698

16611306

http://www.w3.org/2001/XMLSchema#string